Market Overview:
The global nafamostat mesylate market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for nafamostat mesylate in pharmaceutical intermediates, chemical intermediate, and other applications. Additionally, increasing R&D investments for the development of novel therapeutics is also propelling the growth of the global nafamostat mesylate market. However, stringent regulatory norms and high manufacturing costs are restraining the growth of this market.
Product Definition:
Nafamostat mesylate is a protease inhibitor which is used to prevent clotting in the blood. It is important because it can help to prevent serious medical conditions such as heart attack, stroke, and pulmonary embolism.
Purity>98%:
Purity 98% is a new generation of purity-based drug products. It has been designed to meet the growing needs of patients who are suffering from life-threatening diseases such as HIV, cancer, and other immunodeficiency disorders. Purity 98% contains highly potent and effective drugs at reduced doses with improved safety and efficacy profiles compared to existing therapies in use today.
Purity
Purity 98% is a crystalline compound, which has been developed as an intermediate for the synthesis of Nafamostat Mesylate. It is also used in other pharmaceutical applications such as treatment of hereditary angioedema and urticaria.
Application Insights:
The global nafamostat mesylate market is segmented by application into pharmaceutical intermediates, chemical intermediate and others. The chemical intermediate segment held the largest share of over 50% in 2017. Increasing demand for intermediates used in the production of various chemicals including paracetamol, salicylic acid, resveratrol and cephalosporins is expected to drive growth during the forecast period.
Pharmaceuticals are anticipated to be one of the fastest growing segments due to increasing usage as an anti-inflammatory drug across a variety of applications such as osteoarthritis pain management & joint disorder treatment globally. Rising geriatric population base coupled with rising prevalence rates for arthritis will further boost demand for these drugs which may subsequently increase product consumption over the forecast period.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The growth is attributed to the presence of a large number of manufacturers and suppliers coupled with high purity standards. In addition, increasing demand for nafamostat mesylate from major end-use industries such as healthcare & pharmaceuticals, chemicals and others is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rising product demand from emerging countries such as China, India and South Korea coupled with growing manufacturing sectors mainly in automotive, construction materials etc. Furthermore, favorable government initiatives are also expected to boost industry expansion over next eight years.
Growth Factors:
- Increasing prevalence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for nafamostat mesylate in the coming years as it is used for the treatment of various types of cancers.
- Growing awareness about nafamostat mesylate: There is a growing awareness about the benefits of nafamostat mesylate among healthcare professionals and patients alike. This is likely to boost its demand in the near future.
- Rising number of clinical studies on nafamostat mesylate: A large number of clinical studies are being conducted on nafamostat mesylate across the globe, which is indicative of its potential therapeutic benefits. This is likely to fuel its growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nafamostat Mesylate Market Research Report
By Type
Purity>98%, Purity<98%
By Application
Pharmaceutical intermediates, Chemical Intermediate, Others
By Companies
BOC Sciences, MedChemexpress, APExBIO, AK Scientific, Service Chemical, Carbone Scientific, Hairui Chem, Carbosynth, Watson International, Capot Chem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
188
Number of Tables & Figures
132
Customization Available
Yes, the report can be customized as per your need.
Global Nafamostat Mesylate Market Report Segments:
The global Nafamostat Mesylate market is segmented on the basis of:
Types
Purity>98%, Purity<98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical intermediates, Chemical Intermediate, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOC Sciences
- MedChemexpress
- APExBIO
- AK Scientific
- Service Chemical
- Carbone Scientific
- Hairui Chem
- Carbosynth
- Watson International
- Capot Chem
Highlights of The Nafamostat Mesylate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity>98%
- Purity<98%
- By Application:
- Pharmaceutical intermediates
- Chemical Intermediate
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nafamostat Mesylate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nafamostat mesylate is a medication used to treat high blood pressure. It works by reducing the amount of fluid in your blood. This can help lower your blood pressure.
Some of the key players operating in the nafamostat mesylate market are BOC Sciences, MedChemexpress, APExBIO, AK Scientific, Service Chemical, Carbone Scientific, Hairui Chem, Carbosynth, Watson International, Capot Chem.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nafamostat Mesylate Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Nafamostat Mesylate Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Nafamostat Mesylate Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Nafamostat Mesylate Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Nafamostat Mesylate Market Size & Forecast, 2020-2028 4.5.1 Nafamostat Mesylate Market Size and Y-o-Y Growth 4.5.2 Nafamostat Mesylate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity>98%
5.2.2 Purity<98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical intermediates
6.2.2 Chemical Intermediate
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nafamostat Mesylate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nafamostat Mesylate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity>98%
9.6.2 Purity<98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical intermediates
9.10.2 Chemical Intermediate
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity>98%
10.6.2 Purity<98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical intermediates
10.10.2 Chemical Intermediate
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity>98%
11.6.2 Purity<98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical intermediates
11.10.2 Chemical Intermediate
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity>98%
12.6.2 Purity<98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical intermediates
12.10.2 Chemical Intermediate
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity>98%
13.6.2 Purity<98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical intermediates
13.10.2 Chemical Intermediate
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nafamostat Mesylate Market: Competitive Dashboard
14.2 Global Nafamostat Mesylate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BOC Sciences
14.3.2 MedChemexpress
14.3.3 APExBIO
14.3.4 AK Scientific
14.3.5 Service Chemical
14.3.6 Carbone Scientific
14.3.7 Hairui Chem
14.3.8 Carbosynth
14.3.9 Watson International
14.3.10 Capot Chem